XTNT

Xtant Medical Holdings, Inc. (XTNT) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

XTNT’s low R&D intensity at 2.0% of revenue suggests a lighter innovation footprint than peers, but it also limits evidence of differentiated environmental product development.

The company’s capital structure appears manageable with debt-to-equity of 0.65, reducing near-term balance-sheet pressure that can constrain environmental investment versus more leveraged peers.

No disclosed emissions, energy, or waste metrics were provided, leaving XTNT’s operational environmental management harder to assess relative to peers with more transparent reporting.

Absent evidence of material environmental controversies, XTNT appears broadly in line with smaller-cap peers, though disclosure depth remains a relative weakness.

Social

Score:

Stock-based compensation of 2.7% of revenue indicates moderate employee alignment costs, but it does not by itself demonstrate stronger workforce practices than peers.

The provided data contain no workforce, safety, turnover, or customer-impact metrics, limiting visibility into XTNT’s social risk management versus better-disclosed peers.

Limited disclosure on human capital and product responsibility makes it difficult to confirm whether XTNT is ahead of peers on labor or stakeholder outcomes.

XTNT appears neither clearly advantaged nor structurally disadvantaged on social factors, with peer-relative positioning constrained mainly by sparse reporting.

Governance

Score:

XTNT’s net debt to EBITDA of -6.6 implies strong liquidity relative to peers, which can support governance flexibility and reduce refinancing pressure.

A debt-to-equity ratio of 0.65 suggests moderate leverage discipline, comparing favorably with more highly levered peers that face tighter oversight and covenant risk.

R&D spending at 2.0% of revenue indicates restrained capital allocation, but without board, audit, or ownership disclosures, governance quality cannot be rated as strong.

The absence of disclosed controversies or control failures supports a mid-tier governance assessment, though peer leaders typically provide materially richer transparency.

Overall Score

Score:

XTNT’s ESG positioning is broadly average versus peers, with modest balance-sheet discipline offset by limited disclosure across environmental and social dimensions.

Score Driver: Sparse ESG Disclosure Is The Main Constraint On A Stronger Peer-Relative Assessment.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Xtant Medical Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →